<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02381925</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00061739</org_study_id>
    <nct_id>NCT02381925</nct_id>
  </id_info>
  <brief_title>Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism</brief_title>
  <official_title>Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims are:&#xD;
&#xD;
        1. To compare the diagnostic performance of parathyroid four-dimensional CT (4D-CT),&#xD;
           scintigraphy, and ultrasound in patients who underwent parathyroid surgery for primary&#xD;
           hyperparathyroidism.&#xD;
&#xD;
        2. To compare 4D-CT, scintigraphy, and ultrasound for the ability to perform focused&#xD;
           parathyroidectomy, and for rates of persistent hyperparathyroidism and complications&#xD;
           from parathyroid surgery.&#xD;
&#xD;
      Methods The investigators will create a multicenter registry consisting of patients having&#xD;
      parathyroid surgery for primary hyperparathyroidism from July 2009 to June 2016. Initial&#xD;
      participating centers include Duke University Medical Center, University California Los&#xD;
      Angeles (UCLA) and University of Arkansas for Medical Sciences (UAMS).&#xD;
&#xD;
      There will be no intervention in the patient's treatment or imaging. The management will be&#xD;
      determined by the surgeon or clinician supervising the patient's care.&#xD;
&#xD;
      The registry will consist of patient data regarding basic demographics, history of prior&#xD;
      neck/chest surgery or radiation, parathyroid imaging, biochemical evaluation, intraoperative&#xD;
      surgical findings, parathyroid pathology, and surgical outcomes within the first 6 months&#xD;
      (persistent disease, recurrent laryngeal nerve injury, and hypoparathyroidism). Data will be&#xD;
      entered into REDCap with no PHI. The investigators expect to include 3000 patients in the&#xD;
      registry (1000 from Duke).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study never opened due to funding issues&#xD;
  </why_stopped>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>diagnostic performance of imaging</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ability to perform focused parathyroidectomy</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rates of persistent hyperparathyroidism after parathyroidectomy</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>parathyroidectomy surgical complications</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Parathyroid Adenoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The subjects will include all patients, aged 18 years or older, who underwent parathyroid&#xD;
        surgery from July 2009 to July 2016.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients having parathyroid surgery for primary hyperparathyroidism from July 2009 to&#xD;
             June 2016&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age less than 18 years&#xD;
&#xD;
          -  parathyroid carcinoma&#xD;
&#xD;
          -  secondary or tertiary hyperparathyroidism&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>March 3, 2015</study_first_submitted>
  <study_first_submitted_qc>March 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2015</study_first_posted>
  <last_update_submitted>September 17, 2015</last_update_submitted>
  <last_update_submitted_qc>September 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CT</keyword>
  <keyword>Scintigraphy</keyword>
  <keyword>Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Parathyroid Neoplasms</mesh_term>
    <mesh_term>Hyperparathyroidism</mesh_term>
    <mesh_term>Hyperparathyroidism, Primary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

